Fludeoxyglucose Injection
Product Images NDC 60215-411

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose (NDC 60215-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The University Of Texas Md Anderson Cancer Center, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fdg Structure (Fdg Structure)

FDA Label Image

Fdgc Label Update (Compressed Fdgc 2014120401 Val)

FDA Label Image

Fdgp Label Update (Compressed Fdgp 2014093001 Val)

FDA Label Image

Table 2 (Table 2 Comp)

This is a table showing the principal radiation emission data for Fluorine F 18. The table provides information on the percentage of positron (i+) and gamma emissions per disintegration and their corresponding mean energies in keV.*

FDA Label Image

Table 3 (Table3 (3))

This is a table showing the amount of radiation attenuation of 511 KeV photons by lead (Pb) shielding at different shield thicknesses in mm. The coefficient of attenuation is also provided in the table.*

FDA Label Image

Table 4 (Table4 (2))

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.